Transperitoneal Versus Extraperitoneal Approach for Laparoscopic and Robot-Assisted Radical Prostatectomy: A Systematic Review and Meta-Analysis

医学 前列腺切除术 腹腔镜前列腺根治术 荟萃分析 泌尿科 腹腔镜检查 显著性差异 手术切缘 失血 开放性前列腺切除术 并发症 外科 内科学 切除术 前列腺 癌症
作者
Stefanus Purnomo,Agus Rizal Ardy Hariandy Hamid,Moammar Andar Roemare Siregar,Andika Afriansyah,Hendy Mirza,Doddy Hami Seno,Nugroho Hari Purnomo
标识
DOI:10.5152/tud.2023.23008
摘要

To conduct a comparative analysis of outcomes from 2 different surgical approaches, transperitoneal radical prostatectomy (TP-RP) and extraperitoneal radical prostatectomy (EP-RP) in minimally invasive surgery. A comprehensive search was conducted up to September 2022 using 5 online databases, namely PubMed, Cochrane, Scopus, EMBASE, and Science Direct. Studies were screened per the eligibility criteria, and outcomes included operative duration, estimated blood loss (EBL), hospital stay, operative complication, and positive surgical margin. Total of 13 studies compiled of 2387 patients were selected, with TP-RP and EP-RP performed on 1117 (46.79%) and 1270 (53.21%) patients, respectively. Six laparoscopy radical prostatectomy (LRP) studies and 7 robotassisted radical prostatectomy (RARP) studies with 1140 and 1247 patients, respectively, were also included. The EP-RP demonstrated a marked advantage in terms of operative complications (Risk Ratio [RR]=0.78, 95% CI=0.62, 0.98; P=.04), but no significant difference concluded for operative duration, EBL, hospital stay, and surgical margin. In the RARP group, there was a significant difference in operative duration for EP-RARP and TP-RARP (Mean difference [MD]=-17.27, 95% CI=-26.89, -7.65; P=.0004), hospital stay (MD=-0.54, 95% CI=-0.94, -0.14; P=.008), and operative complications (RR=0.7, 95% CI=0.49, 0.99; P=.04). There were no noteworthy variations identified in EBL and surgical margin. Furthermore, the LRP group did not show any significant differences. This study shows that regardless of the techniques used, EP-RP has a lower risk of operative complications than TP-RP, with no significant difference in other outcomes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YT完成签到,获得积分10
2秒前
末末完成签到 ,获得积分10
6秒前
7秒前
时尚若雁完成签到,获得积分10
7秒前
我独舞完成签到 ,获得积分10
8秒前
刘123完成签到 ,获得积分10
8秒前
8秒前
完美萤完成签到,获得积分10
9秒前
Driscoll完成签到 ,获得积分10
9秒前
赘婿应助苏silence采纳,获得10
12秒前
吃瓜米吃瓜米完成签到 ,获得积分10
12秒前
Shinesword发布了新的文献求助10
12秒前
John完成签到 ,获得积分10
16秒前
王娜完成签到,获得积分10
19秒前
无辜的醉波完成签到,获得积分10
19秒前
我是老大应助jindou采纳,获得10
20秒前
21秒前
ncuwzq完成签到,获得积分10
21秒前
小二郎完成签到 ,获得积分10
23秒前
MADAO完成签到 ,获得积分10
24秒前
MinMinma完成签到 ,获得积分10
25秒前
wmm20035完成签到,获得积分10
25秒前
jiajia993完成签到,获得积分10
27秒前
喂喂喂完成签到,获得积分10
28秒前
chencf完成签到 ,获得积分10
29秒前
优秀山水完成签到,获得积分10
31秒前
优秀念柏完成签到,获得积分10
31秒前
32秒前
33秒前
33秒前
贵贵完成签到,获得积分10
34秒前
海派甜心完成签到,获得积分10
35秒前
调皮翅膀完成签到 ,获得积分10
35秒前
Leanne完成签到,获得积分10
37秒前
准静止锋发布了新的文献求助10
39秒前
Shinesword完成签到,获得积分10
39秒前
麦子完成签到 ,获得积分10
40秒前
浅浅殇完成签到,获得积分10
40秒前
40秒前
Cylair完成签到,获得积分10
41秒前
高分求助中
Clinical Epidemiology: The Essentials, 6e 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Graphene Handbook (2019 Edition) 800
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
IEST-RP-CC018: Cleanroom Cleaning and Sanitization: Operating and Monitoring Procedures 600
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6534822
求助须知:如何正确求助?哪些是违规求助? 8328026
关于积分的说明 17840453
捐赠科研通 5636365
什么是DOI,文献DOI怎么找? 2934563
邀请新用户注册赠送积分活动 1910813
关于科研通互助平台的介绍 1769279